NASDAQ:ATNF
Delisted

Cannbiorx Life Sciences Stock Signals

etoro logo Buy ATNF
*Your capital is at risk
$7.04
+0 (+0%)
At Close: Nov 14, 2025

Latest Data & Signals Issued

Below are some of the latest signals issued for CannBioRx Life Sciences Corp

General

Signal Type Signal Value Data
Score 0.000 83 days ( -218.55 %
Last Price $7.04 0 %
Performance History
7 Days
$7.04 $7.04
0%
30 Days
$7.04 $7.04
0%
12 Mos
$2.68 $7.04
162.69%

7/18

Active Buy Signals

Specific Signals

Short Term
Net score: 20.95
Signal Type Signal Value Importance Data
High / Low N/A Very Low $7.04 - $7.04
Trend - 3 mos 0 % High Width: 0 %
Pred. range - 3 mos N/A - N/A Low -100.00 % - -100.00 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Nov 13, 2025 - 2 days
RSI Short Pivot Signal Buy Very Low Sep 02, 2025 - 54 days
Short MA 3 mos Sell Low Aug 18, 2025 - 64 days
Long MA 3 mos Sell Medium Sep 26, 2025 - 36 days
Short/Long MA 3 mos Sell Medium Sep 26, 2025 - 36 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 65.35
Signal Type Signal Value Importance Data
Trend - 12 mos 110.43 % Very High Width: 287.46 %
Pred. range - 12 mos $6.75 - $26.15 High -4.12 % - 271.50 %
Short MA 12 mos Sell Very High Sep 08, 2025 - 50 days
Long MA 12 mos Buy Very High Jul 16, 2025 - 87 days
Short/Long MA 12 mos Buy Very High Jul 18, 2025 - 85 days
Pivot Long Buy Low Aug 15, 2025 - 65 days
RSI Long Pivot Signal Buy Low Sep 11, 2025 - 47 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT CANNBIORX LIFE SCIENCES CORP
CannBioRx Life Sciences
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials t...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE